Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Physiology|February 11, 2020
From Experiments to Simulation: Shear-Induced Responses of Red Blood Cells to Different Oxygen Saturation LevelsElif Ugurel, Senol Piskin, Ali Cenk Aksu, et al.
Biorheology|October 24, 2019
Nitrite may serve as a combination partner and a biomarker for the anti-cancer activity of RRx-001Selma Cirrik, Elif Ugurel, Ali Cenk Aksu, et al.
Analytica Chimica Acta|October 19, 2020
A micropillar-based microfluidic viscometer for Newtonian and non-Newtonian fluidsAdil Mustafa, Aysenur Eser, Ali Cenk Aksu, et al.
Molecular Biology Reports|November 20, 2019
Nesprin-1 impact on tumorigenic cell phenotypesIlknur Sur-Erdem, Muhammed Sajid Hussain, Maria Asif, et al.
Frontiers in Neuroscience|January 4, 2021
Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for GlioblastomaFiliz Senbabaoglu, Ali Cenk Aksu, Ahmet Cingoz, et al.
Clinical Hemorheology and Microcirculation|July 16, 2019
Differential effects of adenylyl cyclase-protein kinase A cascade on shear-induced changes of sickle cell deformabilityElif Ugurel, Philippe Connes, Gokce Yavas, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|May 29, 2018
Bringing Packed Red Blood Cells to the Point of Combat Injury: Are We There Yet?Aytekin Ünlü, Soner Yılmaz, Özlem Yalçın, et al.
Experimental & Molecular Medicine|June 29, 2025
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancerOzlem Yedier-Bayram, Ahmet Cingöz, Ebru Yilmaz, et al.
Cell Death & Disease|August 16, 2022
EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilitiesOzlem Yedier-Bayram, Bengul Gokbayrak, Alisan Kayabolen, et al.
Cell Communication and Signaling : CCS|November 17, 2023
Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survivalEzgi Ozyerli-Goknar, Ezgi Yagmur Kala, Ali Cenk Aksu, et al.
Pageof 2